Skip to main content

Advertisement

SpringerLink
Log in

Jewish ethnicity and prostate cancer mortality in two large US cohorts

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: To investigate prospectively the relationship between Jewish ethnicity and prostate cancer mortality. Methods: Men were selected from white male participants in two large American Cancer Society cohorts: Cancer Prevention Studies I (CPS-I) (enrolled in 1959 and followed through 1972) and II (CPS-II) (enrolled in 1982 and followed through 1996). During the follow-up periods there were 1751 prostate cancer deaths among 417,018 men in CPS-I and 3594 deaths among 447,780 men in CPS-II. Cox proportional hazards modeling was used to compute rate ratios (RR) and to adjust for known and suspected risk factors for prostate cancer. Results: Prostate cancer death rates were substantially lower among Jewish men than other white men in both cohorts (multivariate adjusted rate ratios (RR) = 0.54, 95% CI = 0.38–0.77 in CPS-I; RR = 0.72, 95% CI = 0.61–0.86 in CPS-II). Factors such as tobacco avoidance and measured dietary patterns did not account for this difference. Lower prostate cancer death rates were observed among Jewish men regardless of place of birth of the participants or their parents. Conclusions: Prostate cancer death rates are lower among Jewish men in the US and in Israel than among non-Jewish US white men. This may reflect persistent differences in unknown environmental risk factors or possible genetic susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McMichael AJ, Giles GC (1980) Patterns of gastrointestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 25: 431-437.

    Google Scholar 

  2. Egan KM, Newcomb PA, Longnecker MP, et al. (1996) Jewish religion and risk of breast cancer. Lancet 347: 1645-1646.

    Google Scholar 

  3. Thomas DB, Karagas MR (1996) Migrant studies. In: Schottenfeld D, Fraumeni JF Jr, ed. Cancer Epidemiology and Prevention, 2nd edn. Oxford: Oxford University Press, pp. 236-254.

    Google Scholar 

  4. Tominaga S, Kuroishi T, Aoki K (1998) Cancer mortality statistics in 33 countries 1953-1992, Nagoya, Japan: Roppo Shupan, pp. 35.

    Google Scholar 

  5. Rosenwaike I (1994) Causes of death among elderly Jews in New York City, 1979-1981. Int J Epidemiol 23: 327-332.

    Google Scholar 

  6. Mack TM, Berkel J, Bernstein L, Mack W (1985) Religion and cancer in Los Angeles County. Natl Cancer Inst Monogr 69: 235-245.

    Google Scholar 

  7. Garfinkel L (1985) Selection, follow-up, and analysis in the American Cancer Society prospective studies. Monogr Nat Cancer Inst 67: 49-52.

    Google Scholar 

  8. Hammond EC (1966) Smoking in relation to the death rates of one million men and women. Epidemiological approaches to the study of cancer and other chronic diseases. In: Hanenszel, W. ed. Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. National Cancer Institute Monograph 19. Rockville, MD: US Department of Health, Education, and Welfare, pp. 127-204.

    Google Scholar 

  9. Stellman SD, Garfinkel L (1986) Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. Natl Cancer Inst 76: 1057-1063.

    Google Scholar 

  10. Calle EE, Terrell DD (1993) Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137: 235-241.

    Google Scholar 

  11. World Health Organization (1957) International Statistical Classification of Diseases, Injuries, and Causes of Death, vol. 1. Geneva: World Health Organization.

    Google Scholar 

  12. World Health Organization (1979) International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, vol. 1. Geneva: World Health Organization. 276 C. Rodriguez et al.

    Google Scholar 

  13. Cox DR (1972) Regression models and life tables. JR Stat Soc 34: 187-220.

    Google Scholar 

  14. Thun MJ, Calle EE, Namboodiri MM, et al. (1992) Risk factors for fatal colon cancer in a large prospective study [See comments]. J Natl Cancer Inst 84: 1491-1500.

    Google Scholar 

  15. Kleinbaum GG, Kupper LL, Morgenstern H (1982) Epidemiologic Research: Principles and Quantitative Methods. Beltmont, CA: Lifetime Learning Publications.

    Google Scholar 

  16. Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW (1997) Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 145: 466-475.

    Google Scholar 

  17. Giovannucci E, Rimm EB, Ascherio A, et al. (1999) Smoking and risk of total and fatal prostate cancer in United States Health Professionals. Cancer Epidemiol Biomarkers Prev 8: 277-282.

    Google Scholar 

  18. Coughlin SS, Neaton JD, Sengupta A (1996) Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 143: 1002-1006.

    Google Scholar 

  19. Hsing AW, McLaughlin JK, Hrubec LM, Blot WJ, Fraumeni Jr JF (1991) Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol 133: 437-441.

    Google Scholar 

  20. Key T (1995) Risk factors for prostate cancer. Cancer Surv 23: 63-77.

    Google Scholar 

  21. Hayes RB, Pottern LM, Strickler H, et al. (2000) Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 82: 718-725.

    Google Scholar 

  22. Peters RK, Mack TM, Bernstein L (1984) Parallels in the epidemiology of selected anogenital carcinomas. J Natl Cancer Inst 72: 609-615.

    Google Scholar 

  23. Wideroff L, Schottenfeld D, Carey TE, et al. (1996) Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 28: 115-123.

    Google Scholar 

  24. Suzuki H, Komiya A, Aida S, Ito H, Ryuichi Y, Shimazaki J (1996) Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 28: 318-334.

    Google Scholar 

  25. Cuzick J (1995) Human papillomavirus infection of the prostate. Cancer Surv 23: 91-95.

    Google Scholar 

  26. Cook LS, Koutsky LA, Holmes KK (1994) Circumcision and sexually transmitted diseases. Am J Public Health 84: 197-201.

    Google Scholar 

  27. Parker S, Stewart A, Wren M, Gollow M, Straton J (1983) Circumcision and sexually transmitted diseases. Med J Aust 2: 288-290.

    Google Scholar 

  28. Friedlander Y, Kark JD, Kaufmann NA, Stein Y (1985) Coronary heart disease risk factors among religious groups in a Jewish population sample in Jerusalem. Am J Clin Nutr 42: 511-521.

    Google Scholar 

  29. Kolonel LN, Nomura AMY, Cooney RV (1999) Dietary fat and prostate cancer: current status. J Natl Cancer Inst 91: 414-428.

    Google Scholar 

  30. Giovannucci E, Rimm EB, Wolk A, et al. (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58: 442-447.

    Google Scholar 

  31. Shuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (1998) Vegetable and fruit consumption and prostate cancer risk: a cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 7: 673-680.

    Google Scholar 

  32. Kolonel LN, Hankin JH, Whittemore AS, et al. (2000) Vegetables, fruit, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9: 795-804.

    Google Scholar 

  33. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willet WC (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87: 1767-1776.

    Google Scholar 

  34. Shibata A, Paganini-Hill A, Ross RK, Henderson BE (1992) Intake of vegetables, fruit, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 66: 673-679.

    Google Scholar 

  35. Struewing JP, Horn-Ross PL, Peretz T, et al. (1995) The carrier frequency of the BRCA1 185del AG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11: 198-200.

    Google Scholar 

  36. Struewing JP, Harge P, Wacholder S, et al. (1977) The risk of cancer associated with specific mutations of BRCA1 and BRCA1 among Ashkenazi Jews. N Engl J Med 336: 1401-1408.

    Google Scholar 

  37. Hubert A, Peretz T, Manor O, et al. (1999) The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 65: 921-924.

    Google Scholar 

  38. Park JJ, Irvine RA, Buchanan G, et al. (2000) Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor. Cancer Res 60: 5946-5949.

    Google Scholar 

  39. Chen C (2001) Risk of prostate cancer in relation to polymorphisms of metabolic genes. Epidemiol Rev 23: 30-35.

    Google Scholar 

  40. Makridakis NM, Reichardt KV (2001) Molecular epidemiology of hormone-metabolic loci in prostate cancer. Epidemiol Rev 23: 24-29.

    Google Scholar 

  41. Menck HR, Henderson BE, Pike MC, Martin SP, SooHoo J (1975) Cancer incidence in the Mexican-American. J Natl Cancer Inst 55: 531-536.

    Google Scholar 

  42. Tsugane S, Gotlieb SLD, Laurenti R, Souza JMP, Watanabe S (1989) Mortality and cause of death among first-generation Japanese men in Sao Paulo, Brazil. Int J Epidemiol 18: 647-651.

    Google Scholar 

  43. Kolonel LN, Hinds MW, Hankin JH (1980) Cancer patterns among migrant and native-born Japanese in Hawaii to smoking, drinking, and dietary habits. In: Gelboin HV, MacMahon B, Matsushima T, Sugimura T, Takayama S, Takebe H, eds. Genetics and Enviromental Factors in Experimental and Human Cancer. Tokyo: Japan Scientific Society Press, pp. 327-340.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Surveillance Research, American Cancer Society, National Home Office, 1599 Clifton Road NE, Atlanta, GA, 30329-4251

    Carmen Rodriguez

  2. Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA, USA

    Eric J. Jacobs, Alpa V. Patel, Eugenia E. Calle, Heather Spencer Feigelson, Dorna Fakhrabadi-Shokoohi & Michael J. Thun

Authors
  1. Carmen Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric J. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alpa V. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eugenia E. Calle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Heather Spencer Feigelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dorna Fakhrabadi-Shokoohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael J. Thun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodriguez, C., Jacobs, E.J., Patel, A.V. et al. Jewish ethnicity and prostate cancer mortality in two large US cohorts. Cancer Causes Control 13, 271–277 (2002). https://doi.org/10.1023/A:1015088125968

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015088125968

Search

Navigation